Cite
HARVARD Citation
Froyman, W. et al. (2019). Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study. Lancet oncology. 20 (3), pp. 448-458. [Online].